Nachman Norwood & Parrott’s VivoSim Labs VIVS Stock Holding History

Nachman Norwood & Parrott’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6	Closed	-$1K	–	1088
2020 Q3	$1K	Buy	+6	New	+$773	﹤0.01%	1173

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $100M AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Nachman Norwood & Parrott's VIVS Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of VivoSim Labs (VIVS) in Q4 2020, closing a stake of 6 shares — an estimated $1K sold.

Nachman Norwood & Parrott first reported a position in VIVS in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 46 funds tracked by Wall St. Rank hold VIVS as of Q4 2020.

Nachman Norwood & Parrott reported no remaining VivoSim Labs position as of Q4 2020 after selling out during the quarter.
Nachman Norwood & Parrott sold 6 VivoSim Labs shares in Q4 2020, an estimated $1K.
Nachman Norwood & Parrott first reported a position in VivoSim Labs in Q3 2020 and held it in 1 quarter.
Nachman Norwood & Parrott's VivoSim Labs position peaked at $1K in Q3 2020.
46 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.